BioVie Inc. (BIVI) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated November 10, 2025, details the results of BioVie Inc.'s 2025 Annual Meeting of Stockholders. The meeting was held on November 10, 2025, with a record date of September 22, 2025. At the record date, 7,535,080 shares of Class A Common Stock were outstanding. A quorum was established with 3,417,857 shares present virtually or by proxy.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.
Material Changes and Voting Results
Three proposals were voted upon at the Annual Meeting:
- Proposal 1: Election of Directors. Stockholders elected all six nominees (Amy Chappell, Cuong Do, Kameel Farag, James Lang, Michael Sherman, and Sigmund Rogich) for one-year terms. All nominees received significant "For" votes, ranging from approximately 1,512,422 to 1,517,109, with "Withhold" votes ranging from 36,239 to 40,926.
- Proposal 2: Ratification of Auditors. Stockholders ratified the appointment of EisnerAmper LLP as the independent registered public accounting firm for the fiscal year ending June 30, 2026. The vote was 3,245,049 "For," 141,868 "Against," and 30,940 "Abstain."
- Proposal 3: Equity Incentive Plan Amendment. Stockholders approved an amendment and restatement of the 2019 Omnibus Equity Incentive Plan, increasing the authorized shares for issuance to 3,100,000. The vote was 1,340,062 "For," 207,794 "Against," and 5,492 "Abstain."
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on business outlook, specific risks, contingencies, or unusual items. The document is limited to the reporting of voting results.
Key Facts for Investor Verification
- Verification of the new share authorization limit of 3,100,000 under the amended 2019 Omnibus Equity Incentive Plan.
- Confirmation of the re-election of the current board of directors for the upcoming term.
- Confirmation that EisnerAmper LLP will serve as the independent auditor for the fiscal year ending June 30, 2026.
- Review of the "Against" vote count for the Equity Incentive Plan amendment (207,794 votes), which represents a notable minority opposition compared to the other proposals.